For how we live.
Among 287 people with REM sleep behaviour disorder followed about four years, 15.7% developed a synucleinopathy. Higher coffee intake was linked to a lower risk of progression.
In 20 healthy young adults, closed-loop acoustic stimulation of slow waves boosted word recall, and the benefit tracked a shift in how sleep spindles nested within slow oscillations.
Sleeping apart is increasingly common and can genuinely cut disturbance. But the lab evidence is double-edged: sharing a bed measures as slightly worse sleep yet feels better, and may even boost REM.
Wrist trackers infer light, deep and REM sleep from movement and pulse. Two validation studies find they track total sleep passably but each misjudges the stage breakdown its own way.
Probably not ideal. Even moderate light during sleep measurably raises night-time heart rate and next-morning insulin resistance, and in one large study women who slept with a light or TV on gained more weight.
A warm bedroom measurably degrades sleep, and the best-studied comfortable band sits at roughly 20–25°C. The effect is real but personal, and heat matters more than most people assume.
Knowing you are dreaming and sometimes steering it is real and surprisingly common, and it can be trained. But deliberately inducing it may carry a mental-health cost for some people.
The viral drink pairs tart cherry juice with a magnesium supplement. Both have some human trial data for sleep, but it is thin, small and low-quality — far short of what the trend implies.
The viral countdown says no caffeine 10 hours before bed, no food at 3, no work at 2, no screens at 1. The caffeine and food steps have real evidence behind them; the rest is thinner.
Yes, within limits. Short sleep is linked to more colds and weaker vaccine responses, but the strongest effects turn up when sleep is measured objectively, not from what people report.
When researchers tested people with insomnia, those told to picture an engaging scene fell asleep faster. A vaguer instruction to just distract yourself, the counting-sheep approach, did not.
For most healthy adults the measured difference is small. But side-sleeping has real evidence in three specific situations: nocturnal reflux, obstructive sleep apnoea and late pregnancy.
In the phase 2 Vibrance-1 trial, alixorexton lifted mean sleep latency from about 2 minutes on placebo to 24 or more on the drug. The six-week study was funded by the manufacturer.
The largest synthesis of experimental sleep research finds that shorter, broken or lost sleep flattens positive emotion and ramps up anxiety — and trials that fix sleep improve mental health in turn.
At high doses caffeine reliably provokes anxiety and can trigger panic attacks in vulnerable people. The effect is dose-dependent, habitual drinkers differ, and disrupted sleep is part of the story.
Slow breathing does shift the body toward calm, but the popular 4-7-8 count has almost no direct trial evidence, and the breathwork that has been tested in a large study is a different pattern.
Wellness marketing says reconnecting to the Earth's electrons lowers cortisol, inflammation and pain. The human studies are small, mostly unblinded, and largely produced by the idea's own advocates.
Short sleep is tied to obesity, and experiments suggest the link is partly causal. Adults told to sleep longer ate about 270 fewer calories a day; dieters who slept less lost far less of their weight as fat.
In a driving study, 200 mg of caffeine followed by a nap under 15 minutes cut simulator incidents to 9% of placebo levels, against 34% for caffeine alone. The order is the point.
In midlife women the usual cause is the menopause transition, where hot flushes and night sweats last a median of seven years. In older adults they are common, mostly benign, and rarely a mortality signal.
That heavy, foggy feeling on waking is often sleep inertia — a normal, temporary state, not a sign you slept badly. It bites hardest when you wake from deep sleep or during the biological night.
A large public randomised trial found reading a book in bed nudged sleep quality up. But the format matters: paper helps, while a glowing screen can quietly work against you.
Short courses look well tolerated, but trials rarely run past a few weeks, so long-term safety is untested. Two clearer problems: variable supplement content, and a surge in children's accidental ingestions.
There is no single number. A US expert panel sets wide bands — 12 to 16 hours for infants down to 8 to 10 for teenagers — and warns that regularly falling short is linked to attention, behaviour and learning problems.
Grinding and clenching in sleep is common, and in healthy people experts now class it as a behaviour rather than a disorder. But the evidence on how common it is, and what causes it, is thinner than you would expect.
For a few seconds to a couple of minutes you are awake but frozen, sometimes with a sense of a presence in the room. It is REM sleep intruding into wakefulness — common, frightening and, on its own, harmless.
Nightmare disorder affects about 4% of adults. The treatment with the clearest backing is not a drug but a rehearsal technique that rewrites the dream while you are awake.
Childhood sleepwalking is usually harmless and outgrown. In adults it is rarer but a different proposition — one clinic series found most had done something violent during an episode and one in six had been injured.
A short nap does not wreck most people's night sleep, and can help offset sleep debt. The evidence that gives pause is about long naps: naps of 60 minutes or more track with worse cardiovascular outcomes.
When you eat may shape how you sleep, but the science is young. The clearest signal is that a heavy meal close to bedtime disrupts sleep, while simply shrinking your eating window neither reliably helps nor harms it.
Two things you do in bed have randomised evidence for nocturnal reflux: raising the head of the bed cut acid exposure from 21% to 15%, and a device that kept people on their left side nearly doubled treatment success.
A systematic review of 38 studies rated the evidence that continuous white noise improves sleep as very low, and warned it may worsen sleep for some. A few small studies do find a benefit.
Across the trials, the best-supported remedy is melatonin taken near destination bedtime after crossing several time zones. Light exposure is the other real lever; sleeping pills chase the symptom, not the clock.
Physically acting out dreams is one of the strongest known early signs of Parkinson's and related diseases. In a 1,280-patient cohort, most converted within 12 years — but it is a risk marker, not a verdict.
The idea that sleep flushes toxins from the brain rests largely on mouse experiments. A 2024 study using the same animal measured the opposite direction, and none of it has been shown in humans.
Waking up drenched is common and, the best review found, usually nonspecific — not a sign of shortened life. In women the leading identifiable driver is the menopause, which can last far longer than most expect.
In a 304-veteran trial, prazosin matched placebo on trauma nightmares and sleep quality. Sleep medicine's one recommended treatment for nightmare disorder is a behavioural therapy, not a drug.
In a two-week trial, 100 adults drank coffee or avoided caffeine on random days. Coffee did not raise the upper-chamber skipped beats it was blamed for — but it nudged up lower-chamber ones and cut sleep.
The only systematic review to pool the trials found a warm shower or bath in the evening does speed sleep onset — but the effect is modest and depends on timing the heat one to two hours before bed.
Magnesium is one of the most popular over-the-counter sleep aids, but a 2026 review of the randomised trials concluded the evidence does not support it as a routine treatment for insomnia.
Nocturia is usually blamed on the prostate, but the commonest driver is the kidneys making too much urine overnight. In one trial, low-dose desmopressin trimmed nightly voids and bought about 40 extra minutes of sleep.
Across 17 randomised trials, blue-light filtering lenses showed no clear benefit for eye strain, vision or sleep. The evening-screen problem they target is real; this is not the fix.
The most-cited meta-analysis found a faint signal that valerian might improve sleep, then flagged publication bias and poor-quality trials. Sleep-medicine guidelines suggest against using it.
Meta-analyses of more than a million people find a U-shaped link between sleep duration and death, lowest around seven hours. But this is observational, and reverse causation is the hard part to rule out.
The evidence is real but modest, and stronger for anxiety than for sleep itself. One 120-person trial found a large benefit; pooled analyses across studies find a smaller, more uncertain effect.
One week of five-hour nights cut young men's daytime testosterone by 10–15% in a controlled study. Yet CPAP for sleep apnoea leaves the hormone unmoved, pointing back at body weight.
In the largest pooled cohort studies, the lowest-risk amount of sleep sits closer to seven hours, and both too little and too much track higher mortality. But the curve is a warning sign, not a prescription.
Two meta-analyses find evening exercise leaves sleep largely unchanged or slightly improved. The real exception is vigorous exercise finishing within about an hour of bedtime.
In UK Biobank participants tracked with wrist light sensors, high nighttime light exposure was tied to thickened, weaker heart muscle and 24–33% higher risks of heart attack, stroke and heart failure.
In a 12-person crossover trial, blue-enriched daytime light with reduced evening blue did not cut time spent awake at night, though it nudged a brainwave marker of sleep.
Two small pilot studies in 18-to-25-year-olds found morning bright light on its own shifted circadian timing little, while adding a timed schedule and evening blue-blockers advanced it about 35 minutes.
Dronabinol beat placebo on a nightmare-severity scale in 171 adults, but the effect was moderate and the only serious adverse events occurred in the drug group. Long-term safety is untested.
It is a strip of tape over the lips at night, meant to force nose breathing. The idea is simple; the safety caveat is the part that matters most.
The remedies that work are the ones matched to the cause — nose, mouth, tongue or palate. Here is what the trials support, and the sign that means see a doctor first.
A meta-analysis of 27 studies found a dose-response pattern that runs against the nightcap logic: the sedative effect needs a high dose, and the REM disruption starts at a low one.
Participants on Magtein scored better on memory and reaction-time tests after six weeks. On sleep — the reason most people buy it — an Oura Ring found no measurable difference at all.
Stanford's SleepFM, published in Nature Medicine in January 2026, is the most consequential sleep paper of the year. Its own limitations section explains why it is not yet a clinical test.
External nasal strips have real, repeatable evidence behind mild snoring relief. They have never been shown to treat sleep apnea, and the two problems are not the same problem.
The practice has real theory behind it and a genuine safety warning attached to it. The studies are small, mostly low quality, and say less than either side of the debate claims.
A review screening 14,125 articles found evidence neither for nor against morning or evening training — only that testing and training at the same hour helps. Evening sessions may cost some sleep continuity.
Sleep genuinely gets lighter and more broken with age, though only its efficiency keeps declining after 60. Insomnia itself is not normal ageing, and its first-line treatment is not a pill.
About a third of adults on two continents wake at least three nights a week. The 7.7% who cannot resume sleep carry almost all of the daytime damage — and the cause is often not what the sleeper thinks.
The trend stacks mouth tape, magnesium, trackers and a 'sleepy girl mocktail'. Sleep physicians say one unglamorous treatment carries the evidence; most of the rest is theatre.
An umbrella review graded 249 effect sizes across 67 risk factors for male infertility. More than half were rated very low certainty — and the review contradicts its own table on one of them.
In-lab trials that restricted sleep on weekdays and allowed recovery at the weekend found insulin sensitivity and glucose tolerance still worsened. Population surveys point the other way, and the designs explain why.
A Cochrane review found they may not reduce eye strain and could not determine whether they help sleep. A separate meta-analysis found small effects. Neither found the evidence anyone assumes exists.
A 2,836-pair analysis of the ECHO cohort found one of four compounds associated with parent-reported sleep problems. A Shanghai study of bone density found opposite directions in girls and boys.
A laboratory trial found a light-emitting e-reader really does suppress melatonin and delay the body clock. Two 2026 field studies found the day-to-day effect runs almost entirely through when people go to bed.
Two American guideline bodies grade cognitive behavioural therapy for insomnia as a strong recommendation. Every drug in the sleep-medicine guideline — the ones it endorses and the ones it rejects — came out weak.
A consortium reduced overnight sleep studies to nine composites. Two tracked with better cognition. None tracked with whether a person later developed dementia.
A meta-analysis of 44 cohorts covering 1,864,274 people found the risk signal attached to naps of 30 minutes or more. Below that threshold, no significant risk appeared.
The pooled effect is about seven minutes off the time it takes to fall asleep. The American Academy of Sleep Medicine recommends against it — on evidence it grades as weak in both directions.
The number most people quote is not the number the American Academy of Sleep Medicine and Sleep Research Society agreed on. Their recommendation is a floor, set by expert vote rather than by trial.
A Cochrane review found melatonin reduced jet lag in nine of ten trials. Sleep medicine's own guideline rates it a first-tier option for jet lag disorder. Take it at the wrong hour and it can make things worse.
A twelve-athlete study tested morning, late-afternoon and late-evening sessions across the fasting month — and found the deficit was specific to time of day, not spread evenly across it.
Stress peaked during the fasting month and fell afterwards, but depression and anxiety stayed flat. The consistent finding across every phase was that sleep quality tracked mental health.
The sinuses really do produce nitric oxide at concentrations far above the lower airway. Whether routing more of it through your lungs at night does anything measurable is a separate, unanswered question.
Pooled against the sleep lab, finger-worn devices call sleep versus wake at 87% but fall to the mid-60s on light sleep. An Oura meta-analysis found no significant gap on total sleep time.
The best-validated sleep apnea screener works by being wrong in a specific direction. A 47-study meta-analysis of 26,547 people shows what a questionnaire can and cannot conclude about you.
An analysis of nearly 139,000 Americans finds sedative misuse for sleep clusters among both the socially advantaged and the chronically unwell — pointing to two distinct drivers behind the same behavior.
The NCAA's fifth GOALS study surveyed 20,887 athletes. Sleep is up across almost every sport. Comfort talking to coaches about mental health has barely moved in a decade.
The clearance story about sleep has been brain-centric. A Nature paper reports that in Drosophila, immune cells from the circulation do part of the job — and that blocking them shortens sleep.
Breathing through the mouth in sleep tracks closely with sleep apnea severity. The direction of the arrow is the part the research has not settled, and it changes what any intervention can claim.
A UK Biobank analysis finds high step counts do not offset short sleep. A US cohort finds one-minute bursts matter. And in older adults, most step-count differences vanish after adjusting for age and sex.
The famous Stanford basketball study had eleven players and no control group. Fifteen years on, sleep extension is still the best-supported sleep intervention in sport, and still barely studied.
Among 16-to-24-year-olds in NHANES, those who slept longer on weekends had 41% lower odds of daily depressive symptoms. The survey measured both at the same moment, which limits what can be concluded.
Standard questionnaires found no daytime difference between suvorexant and placebo. Four-times-daily smartphone prompts found fatigue worse in the morning and better later. The trial had 40 people.
A 240-woman randomised trial compared three months of hatha yoga with a time-matched conditioning programme. On every sleep measure, the two groups moved together.
An industry-standard indirect comparison of fezolinetant and elinzanetant found comparable reductions in vasomotor symptoms. Elinzanetant improved sleep disturbance more, without a difference in overall quality of life.
Twenty experts scored three language models on ten common questions. One model cleared the content validity bar on both topics; another scored zero on jet lag.
Forty-two trials show sleep-hygiene education helps a little and helps less than the alternatives. The sleep-medicine guideline suggests clinicians not use it on its own.
Google's PH-LLM beat sampled human experts on multiple-choice tests but only matched them on real cases. A new reporting checklist published the same month explains why such claims are hard to compare.